ImmuPharma
develops drug components for lupus, cancer, pain relief, MRSA and inflammatory diseases... Read moreImmuPharma
develops drug components for lupus, cancer, pain relief, MRSA and inflammatory diseases... Read more
News
Mar 13, 2025
Advfn
ImmuPharma: Immupharma PLC ImmuPharma proves unique Mechanism of Action-P140
Jan 28, 2025
Sharecast
ImmuPharma: ImmuPharma can't explain near-400% stock jump
Jan 28, 2025
Proactiveinvestors
ImmuPharma: Immupharma knows no reason for rocketing shares outside research advance
Jan 28, 2025
Marketscreener
ImmuPharma: ImmuPharma notes share price surge after novel findings
Jan 09, 2025
Marketscreener
ImmuPharma: ImmuPharma plc Announces Breakthrough Findings into Autoimmune Diseases
Jan 08, 2025
Immupharma
ImmuPharma: Immupharma at JP MORGAN CONFERENCE and BIOTECH SHOWCASE 11-16 January 2025, San Francisco
Jan 08, 2025
Proactiveinvestors
ImmuPharma: ImmuPharma looking forward to industry talks in San Francisco next week
Sep 09, 2024
Morningstar
ImmuPharma: ImmuPharma narrows losses in first half as expenses fall
Aug 08, 2024
MarketScreener
ImmuPharma: ImmuPharma : TR1 - Major Holding - Lanstead
Jul 01, 2024
MarketScreener
ImmuPharma: ImmuPharma : 2024 Result of Annual General Meeting - all resolutions passed